These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2549749)

  • 1. [Introduction of an enzyme method for determining pyrophosphate in urine--a comparative study between patients with calculi and normal probands].
    Genester C; Salgado J; Coll R; Conte A; Grases F
    Z Urol Nephrol; 1989 Jul; 82(7):369-73. PubMed ID: 2549749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro.
    Ryall RL; Harnett RM; Marshall VR
    Clin Chim Acta; 1981 May; 112(3):349-56. PubMed ID: 6263523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of pyrophosphate in renal calculi and urine by means of an enzymatic method.
    March JG; Simonet BM; Grases F
    Clin Chim Acta; 2001 Dec; 314(1-2):187-94. PubMed ID: 11718694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M; Anders D; Graef V; Bödeker RH
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a turbidimetric assay to study the effect of urinary components on calcium oxalate precipitation.
    Saso L; Valentini G; Casini ML; Mattei E; Panzironi C; Silvestrini B
    Urol Int; 1998; 60(1):47-52. PubMed ID: 9519421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrophosphate does not influence calcium oxalate or calcium phosphate crystal formation in concentrated whole human urine.
    Hallson PC; Rose GA; Sulaiman S
    Urol Res; 1983; 11(4):151-4. PubMed ID: 6316611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An estimate of the ion-activity product of magnesium ammonium phosphate in urine.
    Tiselius HG; Wall I
    Eur Urol; 1986; 12(5):346-9. PubMed ID: 3780801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential arterial hypertension and stone disease.
    Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary beta 2-microglobulin excretion and renal lithiasis.
    Resnick MI; Munday D; Boyce WH
    Invest Urol; 1980 Sep; 18(2):137-8. PubMed ID: 6157653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infrared spectroscopic studies of renal stones.
    Khaliq A; Ahmed J; Khalid N
    Br J Urol; 1984 Apr; 56(2):135-9. PubMed ID: 6498433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic calcium nephrolithiasis. 1. Differences in urine crystalloids, urine saturation with brushite and urine inhibitors of calcification between persons with and persons without recurrent kidney stone formation.
    Pylypchuk G; Ehrig U; Wilson DR
    Can Med Assoc J; 1979 Mar; 120(6):658-65. PubMed ID: 436047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal stones and urinary pH.
    Metheny N
    Am J Nurs; 1982 Sep; 82(9):1372-5. PubMed ID: 6921926
    [No Abstract]   [Full Text] [Related]  

  • 14. [Non-medicamentous prevention of calcium oxalate urinary calculi].
    Brundig P; Schulz E; Börner R; Haerting R; Janitzky V
    Z Urol Nephrol; 1989 Jun; 82(6):307-15. PubMed ID: 2763727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of inorganic pyrophosphate by normal subjects and patients with renal calculi in north-western India and the effect of diclofenac sodium upon urinary excretion of pyrophosphate in stone formers.
    Sharma S; Vaidyanathan S; Thind SK; Nath R
    Urol Int; 1992; 48(4):404-8. PubMed ID: 1329300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic calcium nephrolithiasis. 2. Differences between hypercalciuric and normocalciuric persons with recurrent kidney stone formation and persons without such a history.
    Wilson DR; Pylypchuk G; Ehrig U
    Can Med Assoc J; 1979 Mar; 120(6):666-9. PubMed ID: 436048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcium and citrate excretion by patients with calculi and healthy probands during induced acidosis].
    Bothor C; Berg W; Donner M; Pirlich W
    Urologe A; 1989 Mar; 28(2):112-5. PubMed ID: 2718293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.